1 completed, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
Follow CPL207280: new trials by email Literature Review of CPL207280 trials Research Report on CPL207280
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy, Safety and Pharmacokinetics Study of CPL207280 After 2-weeks Administration in Subjects With Type 2 Diabetes CPL207280, Placebo - Type 2 Diabetes | Phase 2 | Unknown | Celon Pharma SA | 80 | 2022-01-21 | 2023-02-08 |
| Safety and Pharmacokinetics Study of CPL207280 Compound in Healthy Volunteers. CPL207280, Placebo, Metformin hydrochloride 750 mg - Healthy Volunteers | Phase 1 | Completed | Celon Pharma SA | 68 | 2020-05-27 | 2021-08-18 |
Celon Pharma SA (2)
Poland (2)